Publications by authors named "Masahiro Minoda"
Article Synopsis
- Tocilizumab (TCZ) is an effective treatment for giant cell arteritis (GCA), but its impact on treatment changes and outcomes following relapses or discontinuations due to adverse events (AEs) is not well studied.
- In a retrospective study of 62 GCA patients receiving TCZ, 16% experienced relapses, often after dosage adjustments or stopping TCZ; most relapses were manageable with treatment modifications.
- About 45% of patients experienced AEs, with a small portion discontinuing TCZ; those who used alternative immunosuppressive therapies had better outcomes in managing GCA and avoiding relapses.
Giant cell arteritis (GCA) can produce a variety of visual symptoms. Among these, visual hallucinations are rare and are usually accompanied by visual loss. We encountered a 79-year-old female with GCA who presented with visual hallucinations without visual loss.
View Article and Find Full Text PDF